We are live on ! Find out more
Vanguard Fiduciary Trust

Vanguard Fiduciary Trust Portfolio holdings

AUM $454B
This Fund
S&P 500
This Quarter Est. Return
+25.89%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$454B
AUM Growth
+$58.2B
Cap. Flow
+$1.07B
Cap. Flow %
0.24%
Top 10 Hldgs %
29.47%
Holding
4,173
New
110
Increased
2,643
Reduced
1,032
Closed
97

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$401M
2
AAPL icon
Apple
AAPL
+$206M
3
MSFT icon
Microsoft
MSFT
+$175M
4
AMZN icon
Amazon
AMZN
+$173M
5
CTRA
Coterra Energy
CTRA
+$149M

Sector Composition

Rank Sector Weight
1 Technology 34.13%
2 Financials 13.36%
3 Industrials 10.07%
4 Healthcare 9.55%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMNN icon
3976
Imunon
IMNN
$8.98M
$23.6K ﹤0.01%
13,269
CWD icon
3977
CaliberCos
CWD
$4.58M
$23.4K ﹤0.01%
35,759
NVNO
3978
enVVeno Medical
NVNO
$8.06M
$23.4K ﹤0.01%
2,184
NWTG
3979
Newton Golf Co
NWTG
$6.75M
$23.2K ﹤0.01%
27,609
SONM icon
3980
DNA X Inc
SONM
$4.97M
$23K ﹤0.01%
4,496
CENN icon
3981
Cenntro
CENN
$8.56M
$22.7K ﹤0.01%
6,387
-1
-0% -$4
FLYE
3982
Fly-E Group
FLYE
$2.84M
$22.6K ﹤0.01%
10,714
KTTA icon
3983
Pasithea Therapeutics
KTTA
$16M
$22.6K ﹤0.01%
43,860
MBIO icon
3984
Mustang Bio
MBIO
$4.5M
$22.5K ﹤0.01%
32,120
AKA icon
3985
a.k.a. Brands
AKA
$116M
$22.2K ﹤0.01%
2,072
MGRX icon
3986
Mangoceuticals
MGRX
$9.08M
$21.7K ﹤0.01%
57,163
APUS
3987
Apimeds Pharmaceuticals US
APUS
$6.46M
$21.6K ﹤0.01%
2,404
SNGX icon
3988
Soligenix
SNGX
$8.3M
$21.4K ﹤0.01%
53,914
SST icon
3989
System1
SST
$23.2M
$21.1K ﹤0.01%
9,141
PCSA icon
3990
Processa Pharmaceuticals
PCSA
$7.14M
$20.8K ﹤0.01%
10,857
VRME icon
3991
VerifyMe
VRME
$8.77M
$20.5K ﹤0.01%
33,449
MAMO
3992
Massimo Group
MAMO
$44.1M
$20.5K ﹤0.01%
21,231
GRCE
3993
Grace Therapeutics
GRCE
$45.4M
$19.9K ﹤0.01%
8,750
BCAB icon
3994
BioAtla
BCAB
$5.1M
$19.6K ﹤0.01%
4,730
-739
-14% -$3.13K
IQST
3995
IQSTEL Inc
IQST
$7.54M
$19.4K ﹤0.01%
16,744
ROC
3996
Rank One Computing Corp
ROC
$84.1M
$19.4K ﹤0.01%
+3,674
New +$20.5K
AWX icon
3997
Avalon Holdings
AWX
$10.8M
$19.3K ﹤0.01%
7,743
MEDS
3998
DataMeds AI
MEDS
$4.24M
$19.2K ﹤0.01%
6,191
-1
-0% -$5
PARA
3999
Banzai International
PARA
$4.81M
$19.1K ﹤0.01%
6,308
KITT icon
4000
Nauticus Robotics
KITT
$6.52M
$19K ﹤0.01%
15,473
+1
+0% +$2

Similar funds

Vanguard Fiduciary Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Fiduciary Trust held 4,173 positions worth $454B, up 15% from $396B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Fiduciary Trust opened 110 new positions and exited 97, leaving the 4,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.

  • Vanguard Fiduciary Trust's largest Q2 2026 buy was SpaceX: 3,791,999 shares worth $648M.
  • Vanguard Fiduciary Trust added most to Alphabet (Google) Class A in Q2 2026, an estimated $173M increase.
  • Vanguard Fiduciary Trust's biggest Q2 2026 reduction was Honeywell, cutting an estimated $401M.
  • Vanguard Fiduciary Trust fully exited Coterra Energy in Q2 2026, selling an estimated $149M.
  • Vanguard Fiduciary Trust's ten largest holdings make up 29% of its $454B portfolio in Q2 2026.
  • Vanguard Fiduciary Trust opened 110 new positions and closed 97 in Q2 2026.
  • Vanguard Fiduciary Trust's portfolio value rose 15% quarter-over-quarter to $454B.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.